LANOXIN Safety Questions, LANOXIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LANOXIN. Our extensive database of LANOXIN adverse events and LANOXIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LANOXIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LANOXIN Safety Reports

Total LANOXIN reports: 61.
LANOXIN FDA safety alerts: No.
Reported deaths: 11    Reported hospitalizations: 24.
Take LANOXIN Side Effects Survey or Share Your LANOXIN Story. LANOXIN Usage.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Jan 02, 2007. Female patient, 69 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: cataract, dry skin, halo vision, skin exfoliation. LANOXIN dosage: unknown. During the same period patient was treated with AMIODARONE, COUMADIN, LEVOTHYROXINE, MIRAPEX, TORSEMIDE, XANAX, CALCIUM, FOLIC ACID. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Jan 05, 2007. Female patient, 93 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, peripheral ischaemia, therapeutic agent toxicity. LANOXIN dosage: .06MG PER DAY. During the same period patient was treated with ISOPTIN, ALLOPURINOL, LASIX, MINITRAN, TAVOR, CARDIRENE, MEPRAL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported LANOXIN problem on Jan 19, 2007. Female patient, 79 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea. LANOXIN dosage: unknown. During the same period patient was treated with ASPIRIN, FRUSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Feb 09, 2007. Female patient, 96 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradyarrhythmia, syncope. LANOXIN dosage: unknown. During the same period patient was treated with HYDROCORTISONE, NIFEDIPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Feb 05, 2007. Female patient, child 3 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, atrioventricular block complete, conduction disorder, electrocardiogram pr prolongation, therapeutic agent toxicity, ventricular extrasystoles. LANOXIN dosage: unknown. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Mar 02, 2007. Female patient, 76 years of age, was diagnosed with cardiac failure and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, atrial fibrillation, bradyarrhythmia, bradycardia, hyperkalaemia, hyponatraemia, renal failure. LANOXIN dosage: .13MG PER DAY. During the same period patient was treated with ALLOPURINOL, AMIODAR, CARVEDILOL, LASIX, GLYCERYL TRINITRATE, HUMALOG, HUMULIN R, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from PORTUGAL reported LANOXIN problem on Feb 26, 2007. Female patient, 79 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: coma, haemodynamic instability, nodal rhythm, renal failure acute, therapeutic agent toxicity. LANOXIN dosage: 30 MG. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Mar 09, 2007. Male patient, 71 years of age, was diagnosed with arrhythmia and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood thyroid stimulating hormone increased, cough, hyperkalaemia, iron deficiency anaemia, microcytic anaemia. LANOXIN dosage: .06MG ALTERNATE DAYS. During the same period patient was treated with CORDARONE, FERROUS GLUCONATE, FRUSEMIDE, GLYBURIDE AND METFORMIN, ALDACTONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from THAILAND reported LANOXIN problem on Mar 05, 2007. Female patient, child 12 years of age, weighting 44.00 lb, was diagnosed with cardiac failure congestive and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, nausea, therapeutic agent toxicity, ventricular extrasystoles, ventricular fibrillation, vomiting. LANOXIN dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, FRUSEMIDE, CAPTOPRIL. Patient died.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2007. Male patient, 31 years of age, was diagnosed with atrial fibrillation, arrhythmia supraventricular and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, atrial fibrillation, blood urea increased, cardiac murmur, nausea. LANOXIN dosage: unknown. During the same period patient was treated with FRUSEMIDE, BENAZEPRIL HYDROCHLORIDE, ASPIRIN, FLUTICASONE PROPIONATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Mar 12, 2007. Male patient, 80 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: fatigue, malaise, movement disorder, oedema peripheral, palpitations. LANOXIN dosage: unknown. During the same period patient was treated with NORVASC. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Mar 26, 2007. Male patient, 71 years of age, was diagnosed with arrhythmia and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradyarrhythmia, hyperkalaemia, hypothyroidism. LANOXIN dosage: .06MG ALTERNATE DAYS. During the same period patient was treated with CORDARONE, FERROUS GLUCONATE, FRUSEMIDE, GLYBURIDE AND METFORMIN, ALDACTONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LANOXIN problem on Mar 28, 2007. Male patient, 68 years of age, weighting 171.6 lb, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: decreased activity, dissociation, dizziness, dyspnoea, fatigue, oedema, paraesthesia, ventricular dysfunction. LANOXIN dosage: .125 MG PER DAY. During the same period patient was treated with FUROSEMIDE, ASPIRIN, AMIODARONE, EZETIMIBE, LANSOPRAZOLE. Patient recovered.

LANOXIN problem was reported by a Physician from UNITED STATES on June 26, 2007. Male patient, 79 years of age, was diagnosed with pulmonary fibrosis and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, dizziness. LANOXIN dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, FUROSEMIDE, RISPERDAL, ALTACE, ELTROXIN, WARFARIN, NITROGLYCERIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported LANOXIN problem on June 26, 2006. Female patient, 58 years of age, weighting 118.8 lb, was diagnosed with bronchitis acute and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase mb increased, blood creatinine increased, blood magnesium decreased, blood pressure increased, hyponatraemia, malaise, orthostatic hypotension, syncope. LANOXIN dosage: unknown. During the same period patient was treated with TELITHROMYCIN, HYDROCHLOROTHIAZIDE, FOSINOPRIL, PROGESTERONE, PAROXETINE HYDROCHLORIDE, OMEPRAZOLE, BUDESONIDE, TERBUTALINE. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on July 26, 2006. Male patient, 74 years of age, was diagnosed with angina pectoris and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, decreased appetite, pallor, vomiting. LANOXIN dosage: .13MG PER DAY. During the same period patient was treated with AMLODIPINE, CANRENONE, ENALAPRIL MALEATE, FUROSEMIDE, GLIBENCLAMIDE, GLYCEROL TRINITRATE, WARFARIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on May 05, 2006. Female patient, 76 years of age, weighting 138.2 lb, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cough, dyspnoea, oxygen saturation decreased, pulmonary fibrosis. LANOXIN dosage: .125MG PER DAY. During the same period patient was treated with PACERONE, TENORMIN, BENICAR, NORVASC, COUMADIN. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Male patient, 70 years of age, was diagnosed with ventricular tachycardia and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qrs complex prolonged, haemodialysis, pulse abnormal, renal tubular necrosis, ventricular tachycardia. LANOXIN dosage: unknown. During the same period patient was treated with ESMOLOL. Patient recovered.

Pharmacist from UNITED STATES reported LANOXIN problem on Aug 16, 2006. Female patient, 76 years of age, weighting 149.7 lb, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: hypotension, renal failure acute, therapeutic agent toxicity. LANOXIN dosage: unknown. During the same period patient was treated with ALDACTONE, LASIX, LIPITOR, ASPIRIN, AMBIEN, CELEXA, LEVOXYL, POTASSIUM. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2006. Female patient, 76 years of age, weighting 149.7 lb, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: asthenia, bradycardia, fatigue, hyperkalaemia, hypertension, hypotension, renal failure acute, therapeutic agent toxicity. LANOXIN dosage: unknown. During the same period patient was treated with ALDACTONE, LASIX, LIPITOR, ASPIRIN, AMBIEN, CELEXA, LEVOXYL, POTASSIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on June 07, 2006. Female patient, 86 years of age, was diagnosed with cardiac failure congestive, pain and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood iron increased, hepatic function abnormal, renal impairment. LANOXIN dosage: unknown. During the same period patient was treated with BLOOD TRANSFUSION, CELEBREX, BETAPACE, ELAVIL, LORCET, FUROSEMIDE, HYDROCODONE BITARTRATE. Patient was hospitalized. Patient died on 03/05/2006.

LANOXIN problem was reported by a Pharmacist from UNITED STATES on Sept 06, 2006. Female patient, 80 years of age, weighting 120.8 lb, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, dizziness. LANOXIN dosage: unknown. During the same period patient was treated with CARDIZEM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SAUDI ARABIA reported LANOXIN problem on Sept 04, 2006. Female patient, 63 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: acidosis, chronic obstructive pulmonary disease, chronic respiratory failure, condition aggravated, difficult to wean from ventilator, haemodialysis, nodal arrhythmia, septic shock, therapeutic agent toxicity. LANOXIN dosage: unknown. Patient died.

LANOXIN problem was reported by a Pharmacist from IRELAND on Oct 17, 2006. Male patient, 84 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: anorexia, bradycardia, confusional state, constipation, hallucination, hypokalaemia, renal impairment, vomiting. LANOXIN dosage: unknown. During the same period patient was treated with DURAGESIC, NOVORAPID, PULMICORT, BRICANYL TURBOHALER, SOLPADEINE, LASIX, ELTROXIN, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from ITALY reported LANOXIN problem on Nov 03, 2006. Female patient, 79 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradyarrhythmia, syncope. LANOXIN dosage: .13MG PER DAY. During the same period patient was treated with AMIODARONE HYDROCHLORIDE, FUROSEMIDE, WARFARIN. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 73 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. LANOXIN dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Oct 23, 2006. Female patient, 81 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. LANOXIN dosage: unknown. During the same period patient was treated with VERAPAMIL, CLOPIDOGREL. Patient died.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 85 years of age, was treated with LANOXIN. LANOXIN dosage: unknown. Patient died.

Health Professional from UNITED STATES reported LANOXIN problem on Oct 23, 2006. Female patient, 91 years of age, was treated with LANOXIN. LANOXIN dosage: unknown. Patient died.

LANOXIN problem was reported by a Health Professional from UNITED STATES on Oct 23, 2006. Female patient, 69 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: completed suicide. LANOXIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPAHTE. Patient died.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Oct 23, 2006. Female patient, 78 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. LANOXIN dosage: unknown. Patient died.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 83 years of age, was treated with LANOXIN. LANOXIN dosage: unknown. Patient died.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Oct 23, 2006. Female patient, 63 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, completed suicide. LANOXIN dosage: unknown. Patient died.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 03, 2003. Female patient, 57 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: heart rate decreased, nausea. LANOXIN dosage: unknown. During the same period patient was treated with METOPROLOL, ASPIRIN, VITAMIN, SYNTHROID, VALIUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Oct 03, 2005. Female patient, 73 years of age, was diagnosed with arrhythmia and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: heart rate increased. LANOXIN dosage: .125MG PER DAY. During the same period patient was treated with PREDNISONE, FOLIC ACID, FOSAMAX, VICODIN, TRAMADOL, HYDROCODONE, ARTHROTEC, PROTHIAZIDE. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2005. Female patient, 62 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, headache, nausea, neck pain. LANOXIN dosage: unknown. During the same period patient was treated with DILTIAZEM, COUMADIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Oct 27, 2005. Male patient, 89 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: nipple pain. LANOXIN dosage: unknown. During the same period patient was treated with COUMADIN. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2005. Female patient, 76 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: palpitations. LANOXIN dosage: .125MG PER DAY. During the same period patient was treated with ATENOLOL, FUROSEMIDE, COUMADIN, FOLATE, ZETIA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Dec 19, 2005. Female patient, 59 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased. LANOXIN dosage: .125MG CYCLIC. During the same period patient was treated with DIOVAN, SYNTHROID, PRILOSEC, ZYLOPRIM, ASCORBIC ACID, VITAMIN E, HUMALOG. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 05, 2006. Male patient, 74 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: extrasystoles. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with BENAZEPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, PRAVACHOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Jan 09, 2006. Male patient, 74 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, heart rate increased. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with LISINOPRIL, ALEVE, ERYTHROMYCIN, LEFLUNOMIDE, ASPIRIN. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 16, 2006. Female patient, 59 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: heart rate irregular. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with INDERAL, ALPRAZOLAM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Mar 15, 2006. Female patient, 68 years of age, was diagnosed with atrial fibrillation, hypertension and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: cough. LANOXIN dosage: unknown. During the same period patient was treated with ALTACE, BENICAR HCT, PROTONIX, GLUCOPHAGE, ZETIA, HYDROCHLOROTHIAZIDE. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2006. Female patient, 65 years of age, was diagnosed with heart rate irregular, blood cholesterol increased and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with PREVALITE, GLYBURIDE, LISINOPRIL, GLUCOPHAGE, COUMADIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on May 17, 2006. Female patient was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: asthenia, chest discomfort, fatigue. LANOXIN dosage: unknown. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2006. Male patient, 71 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: erectile dysfunction, hypotension. LANOXIN dosage: unknown. During the same period patient was treated with ALTACE, PREVACID, PRAVACHOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on July 19, 2006. Female patient, 77 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: weight increased. LANOXIN dosage: .125MG PER DAY. During the same period patient was treated with COUMADIN, CORGARD, FOLIC ACID, LASIX. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 67 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: gingival swelling. LANOXIN dosage: unknown. During the same period patient was treated with TOPROL, RYTHMOL, ASPIRIN, PLAVIX, LOTREL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANOXIN problem on Aug 22, 2006. Female patient, 67 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: balance disorder, hepatic pain. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with COUMADIN, NORPACE, SYNTHROID. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Dec 01, 2006. Female patient, 84 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood potassium increased, therapeutic agent toxicity. LANOXIN dosage: unknown. During the same period patient was treated with METHIMAZOLE. Patient recovered.

Consumer or non-health professional from ITALY reported LANOXIN problem on July 19, 2007. Male patient, 85 years of age, was diagnosed with congestive cardiomyopathy and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac failure, hypotension. LANOXIN dosage: unknown. During the same period patient was treated with FUROSEMIDE INTENSOL, POTASSIUM CANRENOATE, RAMIPRIL. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 30, 2007. Female patient, 90 years of age, was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. LANOXIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LANOXIN problem on Aug 02, 2007. Female patient, weighting 183.0 lb, was diagnosed with ventricular fibrillation, coronary artery disease, hypertension and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: blood pressure inadequately controlled, heart rate irregular, pulse abnormal. LANOXIN dosage: unknown. During the same period patient was treated with CARDIZEM CD, CARDIZEM CD. Patient recovered.

LANOXIN problem was reported by a Pharmacist from NETHERLANDS on Aug 02, 2007. Male patient was diagnosed with arrhythmia, asthma and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: vision blurred. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with BISOPROLOLFUMARAT, ACENOCOUMAROL, SERETIDE. Patient recovered.

Pharmacist from NEW ZEALAND reported LANOXIN problem on Aug 15, 2007. Female patient was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: neck mass, pharyngeal oedema. LANOXIN dosage: unknown. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Physician from ITALY on Sept 06, 2007. Female patient, 77 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: asthenia, azotaemia, blood creatinine increased, dyspnoea, pyrexia, vomiting. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with CARDURA, LASIX, NEOLOTAN. Patient was hospitalized. Patient recovered.

Physician from ITALY reported LANOXIN problem on Sept 06, 2007. Female patient, 84 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood creatinine increased, vomiting. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with ALLOPURINOL, NORVASC, LASIX, ACTRAPID, ACTRAPHANE, PLASIL, ZOFENOPRIL. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Physician from ITALY on Sept 06, 2007. Female patient, 93 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, nausea, vomiting. LANOXIN dosage: unknown. During the same period patient was treated with ASPIRIN, BENTELAN, ENAPREN, LASIX, TAVANIC, KANRENOL. Patient was hospitalized. Patient recovered.

Physician from ITALY reported LANOXIN problem on Sept 06, 2007. Female patient, 89 years of age, was diagnosed with atrial fibrillation and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: anorexia, vomiting. LANOXIN dosage: unknown. During the same period patient was treated with GLIBOMET, DIURESIX, TRANEXAMIC ACID. Patient was hospitalized. Patient recovered.

LANOXIN problem was reported by a Consumer or non-health professional from ITALY on Sept 10, 2007. Female patient, 83 years of age, was diagnosed with atrial tachycardia, atrial fibrillation, diabetes mellitus and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, bundle branch block left, bundle branch block right, electrocardiogram qt prolonged, sinus rhythm, therapeutic agent toxicity. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with AMIODARONE HYDROCHLORIDE, FRUSEMIDE, INSULIN, PRAMIPEXOLE DIHYDROCHLORIDE, WARFARIN. Patient was hospitalized. Patient recovered.

Physician from ITALY reported LANOXIN problem on Sept 14, 2007. Female patient, 87 years of age, was diagnosed with cardiac failure and was treated with LANOXIN. After drug was administered, patient experienced the following problems/side effects: bradycardia, dehydration, hypotension, nausea, oliguria, therapeutic agent toxicity, vomiting. LANOXIN dosage: .25MG PER DAY. During the same period patient was treated with NORVASK, ASPIRIN, EPROSARTAN MESILATE, LANSOX. Patient recovered.

Ask Our Patient Community about LANOXIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)